🔎 Trials Near Me

Akèy › Sendwòm myelodisplastik › Missouri › Kansas City

Etid klinik pou Sendwòm myelodisplastik nan Kansas City, MO

7 etid pou Sendwòm myelodisplastik ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Ap rekriteFaz 2
  • University Health Truman Medical Center, Kansas City
  • University of Kansas Cancer Center - Briarcliff, Kansas City
  • University of Kansas Cancer Center - North, Kansas City
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT05564390

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

Ap rekriteFaz 2
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06577441

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Ap rekriteFaz 3
  • American Oncology Partners P.A. MidAmerica Cancer Care, Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07422480

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Ap rekriteFaz 3
  • MidAmerica Cancer Care, Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT06499285

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

Ap rekriteFaz 1
  • University of Kansas Cancer Center, Westwood · 5 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Mar 25, 2026 · NCT03533816

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Kansas City
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Sendwòm myelodisplastik nan lòt vil

Lòt etid nan Kansas City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.